Sameh Saber; Amr A. A. Mahmoud; Noha S. Helal; Eman El-ahwany; Rasha H. Abdelghany. Losartan, an Angiotensin-II Type 1 Receptor Blocker, Attenuates CCl4-Induced Liver Fibrosis With a Positive Impact on Survival in Mice. World J Pharm Sci 2017, 5, 121-126.